Gut microbiota-derived autoinducer-2 regulates lung inflammation through the gut-lung axis

Int Immunopharmacol. 2023 Nov;124(Pt B):110971. doi: 10.1016/j.intimp.2023.110971. Epub 2023 Sep 23.

Abstract

Objective: This study aimed to determine whether autoinducer-2 (AI-2), a crucial bacterial metabolite and quorum sensing molecule, is involved in lung immunity through the gut-lung axis.

Methods: The level of AI-2 and the gut microbiome composition were analysed in the stools from pneumonic patients and the mouse model of acute lung injury. The effect of AI-2 on lung inflammation was further investigated in the mouse model.

Results: The diversity of the faecal microbiota was reduced in pneumonic patients treated with antibiotics compared with healthy volunteers. The AI-2 level in the stool was positively correlated with inflammatory molecules in the serum of pneumonic patients. Intraperitoneal injection of AI-2 reinforced lung inflammation in the acute lung injury mouse model, characterized by increased secretion of inflammatory molecules, including IL-6, IL-1β, C-C chemokines, and CXCL chemokines, which were alleviated by the AI-2 inhibitor D-ribose.

Conclusions: Our results suggested that gut microbiota-derived AI-2 could modulate lung inflammation through the gut-lung axis.

Keywords: Autoinducer-2; Gut microbiota; Gut-lung axis; Lung immunity; Quorum sensing.

MeSH terms

  • Acute Lung Injury*
  • Animals
  • Disease Models, Animal
  • Gastrointestinal Microbiome*
  • Humans
  • Lung
  • Mice
  • Microbiota*
  • Pneumonia*

Substances

  • N-octanoylhomoserine lactone